IDEAYA Biosciences (IDYA) Short-term Investments (2018 - 2026)

IDEAYA Biosciences has disclosed Short-term Investments across 9 years of filings, most recently posting $513.7 million for Q1 2026.

• Short-term Investments for Q1 2026 came in at $513.7 million, down 8.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $513.7 million (down 8.68% YoY), and the FY2025 annual result was $526.6 million, down 11.04% from the prior year.
• Short-term Investments came in at $513.7 million for Q1 2026 at IDEAYA Biosciences, down from $526.6 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $591.9 million in Q4 2024 to a low of $197.3 million in Q1 2022.
• The 5-year median for Short-term Investments is $488.0 million (2025), against an average of $424.2 million.
• Across the five-year window, Short-term Investments surged 116.88% in 2024 and decreased 11.04% in 2025, its largest moves.
• IDEAYA Biosciences' Short-term Investments stood at $296.2 million in 2022, then gained by 24.27% to $368.1 million in 2023, then soared by 60.81% to $591.9 million in 2024, then fell by 11.04% to $526.6 million in 2025, then slipped by 2.45% to $513.7 million in 2026.
• The last three Short-term Investments figures came in at $513.7 million (Q1 2026), $526.6 million (Q4 2025), and $488.0 million (Q3 2025), per Business Quant data.